340B ESP
340B ESP says more that 1,000 covered entities—double the number in May—are submitting 340B drug claims data to it to be able to keep dispensing manufacturers’ drugs to patients at multiple contract pharmacies.

Twice as Many Providers as in May Are Submitting 340B Drug Claims Data to 340B ESP, Pharma Contractor Says

More than 1,000 covered entities—double the number in May—are submitting 340B drug claims data to Second Sight Solutions’ 340B ESP platform to be able to keep dispensing manufacturers’ drugs to patients at multiple contract pharmacies, a senior 340B ESP leader said at a major drug industry conference last week.

340B ESP Product Development Lead Andrew Brownlee gave a presentation Friday at Informa’s 2022 Medicaid Drug Rebate Program Summit in Chicago on 340B ESP’s status and what Second Sight and its parent, Berkeley Research Group, have learned and can now predict. 340B ESP Founder and Business Development Lead Aaron Vandervelde gave a similar presentation in May during 340B Report’s inaugural webinar for subscribers about the platform.  

More than 1,000 covered entities—double the number in May—are submitting 340B drug claims data to Second Sight Solutions’ 340B ESP platform to be able to keep dispensing manufacturers’ drugs to patients at multiple contract pharmacies, a senior 340B ESP leader said at a major drug industry conference last week.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer